News & Events
All News
-
Affinivax, Inc. announces initiation of Phase 1/2 clinical study of ASP3772, its novel pneumococcal MAPS vaccine, in collaboration with Astellas
February 13, 2019 -
Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors, Opening Potential for CAR-T and Other Cellular Medicines in New Settings
January 18, 2019 -
Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders
January 07, 2019 -
The 2019 30-under-30 getting personal to fix the system
January 04, 2019 -
Top 10 ALS Stories of 2018
January 02, 2019 -
Astellas Pharma : buys Potenza Therapeutics for up to $405m
December 21, 2018 -
Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases
November 26, 2018 -
QurAlis Raises $5.5 Million Seed Round - Wins Pfizer Sponsored Golden Ticket to LabCentral
November 19, 2018 -
Biotech ALS-focused QurAlis raises $5.5M in seed money, wins Pfizer ticket to LabCentral
November 19, 2018 -
Servier backs an American startup at LabCentral in the field of mitochondrial health for neurodegenerative and rare diseases
November 14, 2018